Registry Study in MSI/dMMR Solid Tumors

RecruitingOBSERVATIONAL
Enrollment

190

Participants

Timeline

Start Date

October 7, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
DMMR CancerMSI-HSolid Tumor
Trial Locations (10)

100142

RECRUITING

Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijin

Unknown

RECRUITING

Department of Gastroenterology and Hepatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang

RECRUITING

Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou

RECRUITING

Medical Oncology Department of Gastrointestinal Cancer, Liaoning Cancer Hospital & Institute, Shengyang

RECRUITING

Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao

RECRUITING

Department of Gastroenterology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Taiyuan

RECRUITING

Department of Medical Oncology, Peking University First Hospital, Beijing

RECRUITING

Department of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing

RECRUITING

Department of Oncology, Peking University Shougang Hospital, Beijing

RECRUITING

Department of Gastrointestinal Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin

All Listed Sponsors
lead

Peking University Cancer Hospital & Institute

OTHER